Amphotericin B ๐
โ ๏ธ Amphotericin B binds to fungal ergosterol but also interacts with human cholesterol โ explaining its major toxicities, especially nephrotoxicity.
๐ Liposomal amphotericin B (Ambisomeยฎ or equivalent generic) is the preferred formulation in the UK: far less nephrotoxic and better tolerated than conventional amphotericin B deoxycholate.
๐จโโ๏ธ Use only under specialist guidance, with strict dosing and monitoring protocols.
๐ About
- Polyene antifungal antibiotic produced by Streptomyces nodosus.
- Reserved for progressive, potentially life-threatening systemic fungal infections.
- Administration and monitoring require senior specialist involvement (Infectious Diseases, Haematology, or ICU).
โ๏ธ Mode of Action
- Binds preferentially to ergosterol in fungal cell membranes.
- Forms transmembrane pores โ leakage of intracellular K+ and Mg2+ โ cell death.
- Partial affinity for mammalian cholesterol explains renal tubular and infusion toxicities.
๐ฉบ Indications
- Severe or disseminated candidiasis (including candidaemia).
- Cryptococcal meningitis (often combined with flucytosine).
- Invasive aspergillosis and other mould infections (e.g. mucormycosis, fusariosis).
- Visceral leishmaniasis (specialist tropical use).
- Empirical antifungal therapy in high-risk neutropenic fever (specialist setting).
โ ๏ธ Adverse Effects
- Infusion-related reactions: fever, rigors, hypotension, nausea - slow infusion and pre-medication reduce risk.
- Nephrotoxicity: tubular injury โ โcreatinine, โGFR (less with liposomal formulations).
- Electrolyte loss: hypokalaemia, hypomagnesaemia, hyponatraemia โ risk of arrhythmia.
- Haematological: normocytic anaemia (suppression of erythropoietin).
- Occasional hepatotoxicity or allergic reactions.
๐ Drug Interactions
- โ Nephrotoxicity with ciclosporin, tacrolimus, aminoglycosides, or NSAIDs.
- Hypokalaemia increases risk of digoxin toxicity and potentiates QT prolongation.
- Concomitant diuretics or corticosteroids worsen electrolyte loss.
๐ Dose (Refer to BNF / Product Datasheet)
| Formulation / Context |
Recommended Dosing Information |
| ๐ Liposomal Amphotericin B (Ambisomeยฎ / Generic) |
โข 3โ5 mg/kg/day IV infusion over โฅ2 hours.
โข Use only 5% dextrose for dilution (incompatible with saline).
โข No test dose required (unlike conventional amphotericin).
โข Adjust per infection type and response.
|
๐ Conventional Amphotericin B Deoxycholate
(rarely used in UK) |
โข 0.25โ1 mg/kg/day IV in 5% dextrose.
โข Test dose: 1 mg in 20 mL 5% dextrose over 20โ30 min.
โข โ ๏ธ Fatal overdose if >1.5 mg/kg/day.
|
| ๐ Amphotericin B Lipid Complex (Abelcetยฎ) |
โข 5 mg/kg/day IV.
โข Withdrawn from UK market in 2023; retained in some EU/US centres.
|
๐งช Monitoring
- Renal function: U&Es and creatinine at baseline, then โฅtwice weekly (daily if unwell).
- Electrolytes: Kโบ, Mgยฒโบ, Naโบ - replace promptly if low.
- LFTs and FBC: monitor for hepatotoxicity and anaemia.
- Observe during infusion for rigors, anaphylaxis, or arrhythmia.
- Ensure pre-hydration with normal saline before and during therapy.
๐ References
- BNF: Amphotericin B
- UKHSA / Public Health England: Invasive Fungal Infection Guidelines
- MHRA Product Information: Ambisomeยฎ (liposomal amphotericin B)